<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02764970</url>
  </required_header>
  <id_info>
    <org_study_id>26-130 ex 13/14</org_study_id>
    <nct_id>NCT02764970</nct_id>
  </id_info>
  <brief_title>Heart Rate Reducing Therapy in Cardiac CT Using Ivabradine and Bisoprolol</brief_title>
  <official_title>Heart Rate Reducing Therapy With Ivabradine and Bisoprolol Before Coronary Computer Tomographic Angiography in Ambulant Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Out-patients scheduled for coronary computer tomographic angiography (CCTA) were screened
      regarding their baseline heart rate. If heart rate was &gt; 75, patients were pretreated with
      10mg bisoprolol (group 1) or 10mg bisoprolol plus 7.5mg ivabradine (group 2) to reduce heart
      rate one our before CCTA was performed.

      Heart rate, additional use of i.v. bradycardic agents, motion artefacts, radiation dose and
      drug tolerance was monitored.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of the study is to evaluate if ivabradine, an inhibitor of the funny channel (If), in
      addition to bisoprolol is effective in lowering heart rate before coronary computer
      tomographic angiography (CCTA) if administered orally one hour before the scan.

      Out-patients of a single radiology center are included in this retrospective analysis. All
      patients are referred to an ambulant CCTA. All scans are performed with a Siemens Somatom
      Sensation Cardiac 64 Computer Tomograph and analyzed with Siemens Syngo Plaza software.
      Patients with an initial heart rate of â‰¥ 75 bpm are either pretreated with bisoprolol 10mg
      p.o. alone (group 1) or a combination of bisoprolol 10mg and ivabradine 7.5mg p.o. (group 2)
      one hour before the CT scan.

      The change in treatment from bisoprolol only to the combination of bisoprolol and ivabradine
      was introduced as a change in standard treatment independent of the study. The study was only
      plannend and performed as a retrospective analysis after the last patient included into the
      analysis was already treated.

      Additional betablocker is administered intravenously right before the scan if heart rate
      remains elevated.

      The hypothesis is that the addition of ivabradine to bisoprolol results in a pronounced heart
      rate reduction. This heart rate reduction will lead to a reduced need of i.v. bradicardic
      drug use, a reduction in motion artifacts and a reduced radiation dose to to a higher rate of
      flash sequences.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>intraoperative</time_frame>
    <description>number of beats per minute</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Use of i.v. Betablocker</measure>
    <time_frame>time from first ECG in the CT-room to start of CT scan (average of 10 minutes)</time_frame>
    <description>measured in mg metoprolol used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiation Dose</measure>
    <time_frame>intraoperative</time_frame>
    <description>as calculated in mSv</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motion Artifacts</measure>
    <time_frame>intraoperative</time_frame>
    <description>Counted linear misalignments in the ap projection</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">112</enrollment>
  <condition>Bradycardia</condition>
  <arm_group>
    <arm_group_label>ivabradine 7.5mg orally</arm_group_label>
    <description>patients are pretreated with ivabradine and bisoprolol orally before Cardiac CT angiogram</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bisoprolol</arm_group_label>
    <description>patients are only pretreated with bisoprolol orally before Cardiac CT angiogram</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ivabradine 7.5mg orally</intervention_name>
    <description>additive use to the standard medication with bisoprolol</description>
    <arm_group_label>ivabradine 7.5mg orally</arm_group_label>
    <other_name>ivabradine is marketed as Procoralan</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting at the radiology center for a planned coronary computer tomographic
        angiography
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all comer study

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2016</study_first_submitted>
  <study_first_submitted_qc>May 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2016</study_first_posted>
  <results_first_submitted>February 17, 2017</results_first_submitted>
  <results_first_submitted_qc>August 24, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">March 19, 2018</results_first_posted>
  <last_update_submitted>August 24, 2017</last_update_submitted>
  <last_update_submitted_qc>August 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bisoprolol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ivabradine 7.5mg Orally</title>
          <description>patients are pretreated with ivabradine and bisoprolol orally before Cardiac CT angiogram
Ivabradine 7.5mg orally: additive use to the standard medication with bisoprolol</description>
        </group>
        <group group_id="P2">
          <title>Bisoprolol</title>
          <description>patients are only pretreated with bisoprolol orally before Cardiac CT angiogram</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="65"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="65"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ivabradine 7.5mg Orally</title>
          <description>patients are pretreated with ivabradine and bisoprolol orally before Cardiac CT angiogram
Ivabradine 7.5mg orally: additive use to the standard medication with bisoprolol</description>
        </group>
        <group group_id="B2">
          <title>Bisoprolol</title>
          <description>patients are only pretreated with bisoprolol orally before Cardiac CT angiogram</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="65"/>
            <count group_id="B2" value="47"/>
            <count group_id="B3" value="112"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="65"/>
                    <count group_id="B2" value="47"/>
                    <count group_id="B3" value="112"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="62"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="65"/>
                    <count group_id="B2" value="47"/>
                    <count group_id="B3" value="112"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60" spread="11"/>
                    <measurement group_id="B2" value="63" spread="10"/>
                    <measurement group_id="B3" value="61" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="65"/>
                    <count group_id="B2" value="47"/>
                    <count group_id="B3" value="112"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Austria</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="65"/>
                    <count group_id="B2" value="47"/>
                    <count group_id="B3" value="112"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>heart rate</title>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="65"/>
                    <count group_id="B2" value="47"/>
                    <count group_id="B3" value="112"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84.1" spread="6.7"/>
                    <measurement group_id="B2" value="80.7" spread="5.1"/>
                    <measurement group_id="B3" value="82.8" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Heart Rate</title>
        <description>number of beats per minute</description>
        <time_frame>intraoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine 7.5mg Orally</title>
            <description>patients are pretreated with ivabradine and bisoprolol orally before Cardiac CT angiogram
Ivabradine 7.5mg orally: additive use to the standard medication with bisoprolol</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>patients are only pretreated with bisoprolol orally before Cardiac CT angiogram</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate</title>
          <description>number of beats per minute</description>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="65"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.1" spread="9.8"/>
                    <measurement group_id="O2" value="62.7" spread="9.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Use of i.v. Betablocker</title>
        <description>measured in mg metoprolol used</description>
        <time_frame>time from first ECG in the CT-room to start of CT scan (average of 10 minutes)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine 7.5mg Orally</title>
            <description>patients are pretreated with ivabradine and bisoprolol orally before Cardiac CT angiogram
Ivabradine 7.5mg orally: additive use to the standard medication with bisoprolol</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>patients are only pretreated with bisoprolol orally before Cardiac CT angiogram</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Use of i.v. Betablocker</title>
          <description>measured in mg metoprolol used</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="65"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Radiation Dose</title>
        <description>as calculated in mSv</description>
        <time_frame>intraoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine 7.5mg Orally</title>
            <description>patients are pretreated with ivabradine and bisoprolol orally before Cardiac CT angiogram
Ivabradine 7.5mg orally: additive use to the standard medication with bisoprolol</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>patients are only pretreated with bisoprolol orally before Cardiac CT angiogram</description>
          </group>
        </group_list>
        <measure>
          <title>Radiation Dose</title>
          <description>as calculated in mSv</description>
          <units>mSv</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="65"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.9" spread="3.4"/>
                    <measurement group_id="O2" value="13.2" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Motion Artifacts</title>
        <description>Counted linear misalignments in the ap projection</description>
        <time_frame>intraoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine 7.5mg Orally</title>
            <description>patients are pretreated with ivabradine and bisoprolol orally before Cardiac CT angiogram
Ivabradine 7.5mg orally: additive use to the standard medication with bisoprolol</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>patients are only pretreated with bisoprolol orally before Cardiac CT angiogram</description>
          </group>
        </group_list>
        <measure>
          <title>Motion Artifacts</title>
          <description>Counted linear misalignments in the ap projection</description>
          <units>linear misalignments in the ap projectio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="65"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" spread="3.2"/>
                    <measurement group_id="O2" value="3.5" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 hours</time_frame>
      <desc>Clinically significant bradycardia, hypotension and dizziness were checked</desc>
      <group_list>
        <group group_id="E1">
          <title>Ivabradine 7.5mg Orally</title>
          <description>patients are pretreated with ivabradine and bisoprolol orally before Cardiac CT angiogram
Ivabradine 7.5mg orally: additive use to the standard medication with bisoprolol</description>
        </group>
        <group group_id="E2">
          <title>Bisoprolol</title>
          <description>patients are only pretreated with bisoprolol orally before Cardiac CT angiogram</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Assoc. Prof. Dr. Dirk von Lewinski</name_or_title>
      <organization>Medical University of Graz</organization>
      <phone>31638580684 ext 316</phone>
      <email>dirk.von-lewinski@medunigraz.at</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

